LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
20,340,507
Share change
-26,212
Total reported value
$78,922,026
Put/Call ratio
44%
Price per share
$3.88
Number of holders
62
Value change
-$128,678
Number of buys
24
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q4 2020

As of 31 Dec 2020, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,340,507 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, BOXER CAPITAL, LLC, Alyeska Investment Group, L.P., STATE STREET CORP, D. E. Shaw & Co., Inc., MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.